[1] Vogt AS, Arsiwala T, Mohsen M, et al. On iron metabolism and its regulation. Int J Mol Sci,2021, 22 (9):4591.
[2] Wang CY, Babitt JL. Liver iron sensing and body iron homeostasis. Blood,2019, 133 (1): 18-29.
[3] Yanatori I, Kishi F. DMT1 and iron transport. Free Radic Biol Med,2019, 133: 55-63.
[4] Pietrangelo A. Ferroportin disease: pathogenesis, diagnosis and treatment. Haematologica,2017, 102 (12): 1972-1984.
[5] Brissot P, Pietrangelo A, Adams PC, et al. Haemochromatosis. Nat Rev Dis Primers,2018, 4: 18016.
[6] Aschemeyer S, Qiao B, Stefanova D, et al. Structure-function analysis of ferroportin defines the binding site and an alternative mechanism of action of hepcidin. Blood,2018, 131 (8): 899-910.
[7] Silvestri L, Pagani A, Fazi C, et al. Defective targeting of hemojuvelin to plasma membrane is a common pathogenetic mechanism in juvenile hemochromatosis. Blood,2007, 109 (10): 4503-4510.
[8] Xia Y, Babitt JL, Sidis Y, et al. Hemojuvelin regulates hepcidin expression via a selective subset of BMP ligands and receptors independently of neogenin. Blood,2008, 111 (10): 5195-5204.
[9] Wang RH, Li C, Xu X, et al. A role of SMAD4 in iron metabolism through the positive regulation of hepcidin expression. Cell Metab,2005, 2 (6): 399-409.
[10] Mullner EW, Kuhn LC. A stem-loop in the 3' untranslated region mediates iron-dependent regulation of transferrin receptor mRNA stability in the cytoplasm. Cell,1988, 53 (5): 815-825.
[11] Hentze MW, Caughman SW, Rouault TA, et al. Identification of the iron-responsive element for the translational regulation of human ferritin mRNA. Science,1987, 238 (4833): 1570-1573.
[12] Gray NK, Hentze MW. Iron regulatory protein prevents binding of the 43S translation pre-initiation complex to ferritin and eALAS mRNAs. EMBO J,1994, 13 (16): 3882-3891.
[13] Wang J, Pantopoulos K. Regulation of cellular iron metabolism. Biochem J,2011, 434 (3): 365-381.
[14] Kawabata H, Yang R, Hirama T, et al. Molecular cloning of transferrin receptor 2. A new member of the transferrin receptor-like family. J Biol Chem,1999, 274 (30): 20826-20832.
[15] Kawabata H. Transferrin and transferrin receptors update. Free Radic Biol Med,2019, 133: 46-54.
[16] Schmidt PJ, Toran PT, Giannetti AM, et al. The transferrin receptor modulates Hfe-dependent regulation of hepcidin expression. Cell Metab,2008, 7 (3): 205-214.
[17] Mehta K, Busbridge M, Renshaw D, et al. Characterization of hepcidin response to holotransferrin in novel recombinant TfR1 HepG2 cells. Blood Cells Mol Dis,2016, 61: 37-45.
[18] Mehta KJ, Busbridge M, Patel VB, et al. Hepcidin secretion was not directly proportional to intracellular iron-loading in recombinant-TfR1 HepG2 cells: short communication. Mol Cell Biochem,2020, 468 (1-2): 121-128.
[19] Gao J, Chen J, Kramer M, et al. Interaction of the hereditary hemochromatosis protein HFE with transferrin receptor 2 is required for transferrin-induced hepcidin expression. Cell Metab,2009, 9 (3): 217-227.
[20] Goswami T, Andrews NC. Hereditary hemochromatosis protein, HFE, interaction with transferrin receptor 2 suggests a molecular mechanism for mammalian iron sensing. J Biol Chem,2006, 281 (39): 28494-28498.
[21] Schmidt PJ, Fleming MD. Transgenic HFE-dependent induction of hepcidin in mice does not require transferrin receptor-2. Am J Hematol,2012, 87 (6): 588-595.
[22] Wallace DF, Summerville L, Crampton EM, et al. Combined deletion of Hfe and transferrin receptor 2 in mice leads to marked dysregulation of hepcidin and iron overload. Hepatology,2009, 50 (6): 1992-2000.
[23] Ramey G, Deschemin JC, Vaulont S. Cross-talk between the mitogen activated protein kinase and bone morphogenetic protein/hemojuvelin pathways is required for the induction of hepcidin by holotransferrin in primary mouse hepatocytes. Haematologica,2009, 94 (6): 765-772.
[24] Poli M, Luscieti S, Gandini V, et al. Transferrin receptor 2 and HFE regulate furin expression via mitogen-activated protein kinase/extracellular signal-regulated kinase (MAPK/Erk) signaling. Implications for transferrin-dependent hepcidin regulation. Haematologica,2010, 95 (11): 1832-1840.
[25] McDonald CJ, Wallace DF, Ostini L, et al. Parenteral vs. oral iron: influence on hepcidin signaling pathways through analysis of Hfe/Tfr2-null mice. Am J Physiol Gastrointest Liver Physiol,2014, 306 (2): G132-139.
[26] Khayat AA, Suchi M, Vitola B. A rare case of a 2-year-old boy with alagille syndrome and type 3 hereditary hemochromatosis with TFR2 mutation. J Pediatr Gastroenterol Nutr,2019, 68 (4): e68-e70.
[27] Lv T, Zhang W, Xu A, et al. Non-HFE mutations in haemochromatosis in China: combination of heterozygous mutations involving HJV signal peptide variants. J Med Genet,2018, 55 (10): 650-660.
[28] Wang Y, Du Y, Liu G, et al. Identification of novel mutations in HFE, HFE2, TfR2, and SLC40A1 genes in Chinese patients affected by hereditary hemochromatosis. Int J Hematol,2017, 105 (4): 521-525.
[29] Hawula ZJ, Secondes ES, Wallace DF, et al. The effect of the flavonol rutin on serum and liver iron content in a genetic mouse model of iron overload. Biosci Rep,2021, 41 (7)
[30] Kawabata H, Fleming RE, Gui D et al. Expression of hepcidin is down-regulated in TfR2 mutant mice manifesting a phenotype of hereditary hemochromatosis. Blood,2005, 105 (1): 376-381.
[31] Drake SF, Morgan EH, Herbison CE, et al. Iron absorption and hepatic iron uptake are increased in a transferrin receptor 2 (Y245X) mutant mouse model of hemochromatosis type 3. Am J Physiol Gastrointest Liver Physiol,2007, 292 (1): G323-328.
[32] Kleven MD, Jue S, Enns CA. Transferrin receptors TfR1 and TfR2 bind transferrin through differing mechanisms. Biochemistry,2018, 57 (9): 1552-1559. |
